Factors Associated with Hospital Length of Stay and Adverse Events following Percutaneous Ablation of Lung Tumors
To explore the association between risk factors established in the surgical literature and hospital length of stay (HLOS), adverse events, and hospital readmission within 30 days after percutaneous image-guided thermal ablation of lung tumors. This bi-institutional retrospective cohort study include...
Gespeichert in:
Veröffentlicht in: | Journal of vascular and interventional radiology 2023-05, Vol.34 (5), p.759-767.e2 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | To explore the association between risk factors established in the surgical literature and hospital length of stay (HLOS), adverse events, and hospital readmission within 30 days after percutaneous image-guided thermal ablation of lung tumors.
This bi-institutional retrospective cohort study included 131 consecutive adult patients (67 men [51%]; median age, 65 years) with 180 primary or metastatic lung tumors treated in 131 sessions (74 cryoablation and 57 microwave ablation) from 2006 to 2019. Age-adjusted Charlson Comorbidity Index, sex, performance status, smoking status, chronic obstructive pulmonary disease (COPD), primary lung cancer versus pulmonary metastases, number of tumors treated per session, maximum axial tumor diameter, ablation modality, number of pleural punctures, anesthesia type, pulmonary artery–to–aorta ratio, lung densitometry, sarcopenia, and adipopenia were evaluated. Associations between risk factors and outcomes were assessed using univariable and multivariable generalized linear models.
In univariable analysis, HLOS was associated with current smoking (incidence rate ratio [IRR], 4.54 [1.23–16.8]; P = .02), COPD (IRR, 3.56 [1.40–9.04]; P = .01), cryoablations with ≥3 pleural punctures (IRR, 3.13 [1.07–9.14]; P = .04), general anesthesia (IRR, 10.8 [4.18–27.8]; P < .001), and sarcopenia (IRR, 2.66 [1.10–6.44]; P = .03). After multivariable adjustment, COPD (IRR, 3.56 [1.57–8.11]; P = .003) and general anesthesia (IRR, 12.1 [4.39–33.5]; P < .001) were the only risk factors associated with longer HLOS. No associations were observed between risk factors and adverse events in multivariable analysis. Tumors treated per session were associated with risk of hospital readmission (P = .03).
Identified preprocedural risk factors from the surgical literature may aid in risk stratification for HLOS after percutaneous ablation of lung tumors, but were not associated with adverse events.
[Display omitted] |
---|---|
ISSN: | 1051-0443 1535-7732 |
DOI: | 10.1016/j.jvir.2022.12.013 |